September 2016
Volume 57, Issue 12
Open Access
ARVO Annual Meeting Abstract  |   September 2016
Synapse-like structures on retracting end-bulbs in the optic nerve of the DBA/2J mouse model of glaucoma
Author Affiliations & Notes
  • Matthew A Smith
    Pharmaceutical Sciences, Northeast Ohio Medical University, Rootstown, Ohio, United States
  • Denise M Inman
    Pharmaceutical Sciences, Northeast Ohio Medical University, Rootstown, Ohio, United States
  • Christine M Dengler-Crish
    Pharmaceutical Sciences, Northeast Ohio Medical University, Rootstown, Ohio, United States
  • Jerry Silver
    Neurosciences , Case Western Reserve University, Cleveland, Ohio, United States
  • Samuel D Crish
    Pharmaceutical Sciences, Northeast Ohio Medical University, Rootstown, Ohio, United States
  • Footnotes
    Commercial Relationships   Matthew Smith, None; Denise Inman, None; Christine Dengler-Crish, None; Jerry Silver, None; Samuel Crish, None
  • Footnotes
    Support  NIH Grant EY022358
Investigative Ophthalmology & Visual Science September 2016, Vol.57, 2532. doi:
  • Views
  • Share
  • Tools
    • Alerts
      ×
      This feature is available to Subscribers Only
      Sign In or Create an Account ×
    • Get Citation

      Matthew A Smith, Denise M Inman, Christine M Dengler-Crish, Jerry Silver, Samuel D Crish; Synapse-like structures on retracting end-bulbs in the optic nerve of the DBA/2J mouse model of glaucoma. Invest. Ophthalmol. Vis. Sci. 2016;57(12):2532.

      Download citation file:


      © 2017 Association for Research in Vision and Ophthalmology.

      ×
  • Supplements
Abstract

Purpose : Axon degeneration in the optic nerve separates retinal ganglion cells from their major source of survival factors. Typically, disconnection of cells from their targets through axon transection produces extensive die-back and neurotrophin deprivation-mediated apoptosis. However, retinal ganglion cell somata in the retina and end-bulbs in the optic nerve persist for a significant period of time in the DBA/2J mouse model of glaucoma. Other neurodegenerations have proposed an “entrapment” phenomenon where end-bulbs form synapse-like interactions with glial cells within their tracts. The mechanism of this entrapment appears to include neuotrophin provision; ultimately, the interaction prevents regeneration. We identified end-bulbs in the DBA/2J optic nerve and examined them for synapse-like characteristics.

Methods : DBA/2J mice and DBA/2J-Gpnmb+ (control) mice received bilateral intravitreal injections of cholera toxin B (CTB). After seventy-two hours, animals were perfused and optic nerves were microdissected, longitudinally sectioned, and stained for the presynaptic density marker bassoon, the axonal marker heavy-chain neurofilament, and brain-derived neurotrophic factor (BDNF).

Results : In both DBA/2J mice up to 9 months old and controls, end-bulbs within the optic nerve were rarely observed. We found very little bassoon immunoreactivity and evenly distributed BDNF staining along the length of these nerves. As previously reported, aged (14 month old) DBA/2J optic nerve exhibited a large number of end-bulbs characteristic of distal axonopathy. These end-bulbs consisted of large swellings showing accumulations of CTB and neurofilaments without any evidence of the axon extending beyond this structure. Within the bulbs, extensive bassoon-positive puncta on the surface of these end bulbs were located in close proximity to BDNF-positive cells. Importantly, bead-of-pearls type axonal swellings (CTB-positive varicosities along a continuous axon) did not exhibit bassoon-positive puncta, nor were they associated with BDNF-positive cells, indicating that the end bulb bassoon puncta were not merely accumulated cargo being transported along the axon.

Conclusions : These findings indicate that retracting RGC axons form synapse-like structures in the optic nerve—suggesting a possible mechanism that contributes to the somatic and axon segment persistence during pathology in this model.

This is an abstract that was submitted for the 2016 ARVO Annual Meeting, held in Seattle, Wash., May 1-5, 2016.

×
×

This PDF is available to Subscribers Only

Sign in or purchase a subscription to access this content. ×

You must be signed into an individual account to use this feature.

×